Detalles de la búsqueda
1.
Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial.
Arterioscler Thromb Vasc Biol
; 37(2): 350-358, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27932353
2.
Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Arterioscler Thromb Vasc Biol
; 36(3): 491-500, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26821947
3.
Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes.
Circulation
; 129(8): 896-906, 2014 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-24305567
4.
Association of Serum Oxysterols with Cholesterol Metabolism Markers and Clinical Factors in Patients with Coronary Artery Disease: A Covariance Structure Analysis.
Nutrients
; 15(13)2023 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37447327
5.
Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial.
J Atheroscler Thromb
; 30(8): 907-918, 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36450458
6.
Comparison of Endothelial Dysfunction in Coronary Arteries with Bare Metal and 2nd-Generation Drug-Eluting Stents.
J Atheroscler Thromb
; 29(3): 379-392, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33612554
7.
Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apoe-/- Mice.
J Atheroscler Thromb
; 29(1): 111-125, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33455994
Resultados
1 -
7
de 7
1
Próxima >
>>